228 related articles for article (PubMed ID: 25453577)
1. High-intensity focused ultrasound: noninvasive treatment for local unresectable recurrence of osteosarcoma.
Yu W; Tang L; Lin F; Yao Y; Shen Z; Zhou X
Surg Oncol; 2015 Mar; 24(1):9-15. PubMed ID: 25453577
[TBL] [Abstract][Full Text] [Related]
2. Significance of HIFU in local unresectable recurrence of soft tissue sarcoma, a single-center, respective, case series in China.
Yu W; Tang L; Lin F; Jiang L; Shen Z
Surg Oncol; 2019 Sep; 30():117-121. PubMed ID: 31500773
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma: limb salvaging treatment by ultrasonographically guided high-intensity focused ultrasound.
Li C; Wu P; Zhang L; Fan W; Huang J; Zhang F
Cancer Biol Ther; 2009 Jun; 8(12):1102-8. PubMed ID: 19448402
[TBL] [Abstract][Full Text] [Related]
4. Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer.
Wang K; Chen Z; Meng Z; Lin J; Zhou Z; Wang P; Chen L; Liu L
Int J Hyperthermia; 2011; 27(2):101-7. PubMed ID: 21219135
[TBL] [Abstract][Full Text] [Related]
5. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive treatment of malignant bone tumors using high-intensity focused ultrasound.
Li C; Zhang W; Fan W; Huang J; Zhang F; Wu P
Cancer; 2010 Aug; 116(16):3934-42. PubMed ID: 20564113
[TBL] [Abstract][Full Text] [Related]
7. Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience.
Chou AJ; Merola PR; Wexler LH; Gorlick RG; Vyas YM; Healey JH; LaQuaglia MP; Huvos AG; Meyers PA
Cancer; 2005 Nov; 104(10):2214-21. PubMed ID: 16206297
[TBL] [Abstract][Full Text] [Related]
8. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.
Cheung TT; Poon RT; Jenkins CR; Chu FS; Chok KS; Chan AC; Tsang SH; Dai WC; Yau TC; Chan SC; Fan ST; Lo CM
Liver Int; 2014 Jul; 34(6):e136-43. PubMed ID: 24451026
[TBL] [Abstract][Full Text] [Related]
9. High-intensity focused ultrasound ablation combined with systemic therapy for unresectable colorectal cancer liver metastasis: A propensity score-matched analysis.
Tang F; Zhong Q; Ni T; Xue Y; Wu J; Deng R; Zhang Q; Li Y; He X; Yang Z; Zhang Y
Cancer Med; 2023 Dec; 12(24):21985-21995. PubMed ID: 38032013
[TBL] [Abstract][Full Text] [Related]
10. Primary bone malignancy: effective treatment with high-intensity focused ultrasound ablation.
Chen W; Zhu H; Zhang L; Li K; Su H; Jin C; Zhou K; Bai J; Wu F; Wang Z
Radiology; 2010 Jun; 255(3):967-78. PubMed ID: 20501734
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
12. First experience of high-intensity focused ultrasound combined with transcatheter arterial embolization as local control for hepatoblastoma.
Wang S; Yang C; Zhang J; Kong XR; Zhu H; Wu F; Wang Z
Hepatology; 2014 Jan; 59(1):170-7. PubMed ID: 23813416
[TBL] [Abstract][Full Text] [Related]
13. High intensity focused ultrasound ablation for patients with inoperable liver cancer.
Chen L; Wang K; Chen Z; Meng Z; Chen H; Gao H; Wang P; Zhu H; Lin J; Liu L
Hepatogastroenterology; 2015; 62(137):140-3. PubMed ID: 25911884
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound.
Wu F; Wang ZB; Jin CB; Zhang JP; Chen WZ; Bai J; Zou JZ; Zhu H
Ultrasound Med Biol; 2004 Apr; 30(4):511-7. PubMed ID: 15121253
[TBL] [Abstract][Full Text] [Related]
15. HIFU for the treatment of difficult colorectal liver metastases with unsuitable indications for resection and radiofrequency ablation: a phase I clinical trial.
Yang T; Ng DM; Du N; He N; Dai X; Chen P; Wu F; Chen B; Fan X; Yan K; Zhou X; Dong M; Zheng Z; Gu L
Surg Endosc; 2021 May; 35(5):2306-2315. PubMed ID: 32435962
[TBL] [Abstract][Full Text] [Related]
16. [High-intensity focused ultrasound (HIFU) for tumor pain relief in inoperable pancreatic cancer : Evaluation with the pain sensation scale (SES)].
Marinova M; Strunk HM; Rauch M; Henseler J; Clarens T; Brüx L; Dolscheid-Pommerich R; Conrad R; Cuhls H; Radbruch L; Schild HH; Mücke M
Schmerz; 2017 Feb; 31(1):31-39. PubMed ID: 27402264
[TBL] [Abstract][Full Text] [Related]
17. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
[TBL] [Abstract][Full Text] [Related]
18. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
Hawkins DS; Arndt CA
Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080
[TBL] [Abstract][Full Text] [Related]
19. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
[TBL] [Abstract][Full Text] [Related]
20. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
